Chronic Respiratory- Adults Flashcards

1
Q

asthma

A

“Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation..”
o Acute inflammation that is reversible. As reaction continues, the airway lumen becomes obstructed by thick secretions and infiltration of lymphocytes and eosinophils which go on to form mucus plugs →death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

asthma: s/s

A

o Wheezing, recurrent
* Shortness of breath, recurrent
o Chest tightness
* Cold often “goes to the chest” and takes more than 10 days to improve
o Cough
* May be the only symptom in up to 57% of patients(“cough variant”)
* Asthma should be considered in the differential diagnosis of all patients with a chronic cough
* Clue: Cough is worse at night
* Nighttime awakening
o Other
* Symptoms that worsen with exercise, viral infection, inhalant allergens, irritants, weather changes, strong emotions, menses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

asthma: taking a history

A

o Symptoms/Triggers:
* Pattern is important
* Night time, in response to irritants, related to exercise, potential triggers at home/work/school, change in environment
* Are symptoms episodic?
o Personal/Family History:
* Personal or family history of atopy
* Prior personal hx of inhaler use, frequent chest colds, etc
* History of childhood asthma/asthma symptoms
o Social History
* Occupational history, smoking history
o Concomitant symptoms
* Symptoms such as chest pain, lightheadedness, syncope or palpitations are concerning for alternative cardiac etiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

physical exam

A

o Vital signs: T, P, R, BP, SpO2
o General survey: Breathlessness(able to speak in full sentences?), alertness, preferred position (sitting, hunched forward)
o HEENT: Nasal polyps? allergic rhinitis? infection? Med SE’s like thrush?
o Cardiac:
* Tachycardia (may reflect med SE’s or stress response)
* Bradycardia (may precede respiratory arrest in severe asthma)
o Skin: Diaphoresis? Cyanosis? Concurrent eczema(atopic dermatitis)?
o Respiratory
* Rate? Accessory muscles? Retractions?
* Wheezing:
* expiratory at first, with worsening exacerbation inspiratory and expiratory may be heard
* In a severe exacerbation with significant obstruction wheezing may not be appreciated due to lack of air movement
* Respiratory exam may be normal in a person with asthma not experiencing an exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

confirmation of dx of asthma

A

The demonstration of variable expiratory airflow limitation, preferably by spirometry
* Reduced FEV1
* Increase in FEV1 >15 percent after bronchodilator
* If normal spirometry: Repeat when symptomatic, serial home PEF, bronchoprovocation testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

peak flow measurement

A
  • Often used after diagnosis to objectively monitor symptoms and response to treatment
  • Commonly used in sites where spirometry is not available
  • Requires adequate training on proper use and motivation to self monitor
  • Predicted values based on age/gender/height
  • Always record a baseline “personal best” reading when asthma is under reasonable control.
  • Use this for comparison during exacerbations.
  • Not reliable in children under 5 or with mild asthma
  • Green Zone: Good: 80-100% Best
  • Yellow Zone: Caution: 50-80%
  • Red Zone: Danger <50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asthma: Treatment

A

GINA Option 1: for pts using ICS as a reliver
Mild intermittent asthma
* Low dose ICS with LABA (formoterol)

Mild persistent asthma
* Low dose maintenance ICS with LABA

Moderate persistent asthma
* Medium dose maintenance ICS with LABA

Moderate severe persistent asthma
* Add LAMA, consider high dose ICS maintenance with LABA

GINA Option 2: for pts using SABA as a reliver
Mild intermittent asthma
* ICS whenever SABA taken

Mild persistent asthma
* Low dose ICS

Moderate persistent asthma
* Low dose ICS and LABA

Moderate severe asthma
* Add on LAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

asthma: pt education

A
  • Smoking cessation
    o Motivational Interviewing
  • Proper use of inhalers
    o Check expiration dates of inhalers.
    o Renew inhalers at annual PE
  • Asthma Action Plan
    o Every patient with asthma should have an asthma action plan
    o Many schools will ask for one
  • Spacers
    o Use of spacer for children, elderly or poor technique
  • Allergy Avoidance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

allergies

A

o IgE Antibody is produced by plasma cells beneath the mucosal surfaces of the eyes, upper and lower respiratory tracts, skin and gut
o Enter circulation & binds to receptors on mast cells
o Once the binding occurs, the person is sensitized.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

allergies: s/s

A
  • Skin –> atopic dermatitis (eczema)
  • Nasal Mucosa –> allergic rhinitis
  • Respiratory Tract –> asthma
  • GI Tract –> vomiting, diarrhea
  • Blood Vessels (systemic i.e. anaphylaxis) –> vasodilation, loss of blood pressure, bronchoconstriction, death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

atopy

A

Refers to the genetic tendency to develop allergic diseases such as allergic rhinitis, asthma and atopic dermatitis (eczema).
o Associated with heightened immune responses to common allergens, especially inhaled allergens and food allergens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

allergic rhinitis

A
  • Inflammation of nasal sinus cavity
  • Response to viruses, allergens, environmental or occupational irritants
  • Increased irritation to the epithelial lining of nasal cavity leads to increased nasal congestion and secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

risk factors: allergic rhinits

A

o Family hx of atopy
o Male sex
o Birth during pollen season
o Early antibiotic use
o Exposure to indoor allergens
o Serum IgE >100 int. units / mL before age 6
o Presence of allergen-specific immunoglobulin E (IgE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

triggers allergic rhinits

A

o Exposure to indoor / outdoor allergen leads to symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

seasonal allergic rhinitis

A

o Pollen, trees, flowers in spring
o Grasses in summer
o Ragweed in fall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

perennial: allergic rhinitis

A

o Not seasonal
o Triggered by environmental triggers
o Animal dander, dust mites, foods, insect stings, cockroach droppings, mold spores, chemicals

17
Q

history of allergic rhinitis

A

o Detailed symptom history
o Social review
* occupation, home environment, new pets, tobacco or drug use
o Medication review
o Environmental history
* Dust mites, animal dander and indoor allergens should be suspected (heating systems disseminate dust particles)
o Seasonal symptoms
* Late spring / early summer – grass pollen
* Later summer / early fall – weed pollen
* Later winter / early spring – tree pollen

18
Q

s/s allergic rhinitis

A

o Paroxysmal Sneezing
o Nasal congestion
o Rhinorrhea
o Post-nasal drip
o Taste / smell disturbance
o Mucosal Swelling
o Obstruction
o Conjunctivitis
o Nasal-ocular and pharyngeal itching
o Dry mouth
o In more severe cases – fatigue, headache

19
Q

exam findings: allergic rhinits

A

o Pale nasal mucosa with turbinate enlargement
o Clear nasal secretions
o TM effusion
o Mucus, crusting or bleeding
o Allergic shiners heavy bags under eyes
o Enlarged tonsils
o Post-nasal drip
o “Allergic salute”

20
Q

diagnostics allergic rhinits

A

o Not typically necessary
o History can provide much information
o Allergy skin testing
* Performed if symptoms persist and diagnosis is not clear, or not responding to pharmacologic treatment

21
Q

tx allergic rhinits

A

o Environmental conrol
* Outdoor allergens
* Indoor allergens
o Intranasal glucocorticoids
* Considered 1st line after environmental control
* Low systemic exposure
* Both relieves and prevents nasal congestion
* May take days to weeks for full effect
* Side effects include nasal burning, dryness, epistaxis, pharyngitis
* Available options: fluticasone propionate (flonase), mometasone furoate (Nasonex), fluticasone furoate (flonase sensimist) (2nd generation preferred)
o Oral antihistamines
* Less effective for nasal congestion, but do help with sneezing, pruritis and rhinorrhea
* May be useful for patients who don’t respond to intranasal steroid
* 1st generation: less preferred – diphenhydramine (Benadryl), hydroxyzine
* 2nd Generation: preferred - cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra)
o Saline irrigation
* Spray bottle, neti pot, plastic bottle
o Other nasal sprays
* Antihistamine sprays, cromolyn sodium spray  less effective

22
Q

anaphylaxis

A

An acute life-threatening systemic event associated with a potentially life-threatening hypersensitivity reaction.”
o Multiple systems involved (CV, Respiratory, Skin, GI, CNS)

23
Q

anaphylaxis triggers

A

o Common: foods, medications, insect venom, latex, occupational inhalants, IV dye, blood products
o Non-immunologic triggers: cold air, exercise, heat

24
Q

s/s anaphylaxis

A

o Hives, itching, low BP, high HR, SOB, wheezing, flushing, vomiting, anxiety, lightheadedness
o Symptoms usually occur within 5-30 minutes
o Biphasic reactions (2nd acute reaction) occur hours after the first despite no re-exposure
 Usually, 8 hours later but can be up to 72 hours later.
o Intensity of hypersensitivity reactions are not related.
o Clinical presentation pruritic dermal rashes  severe systemic manifestation.

25
Q

red flags anaphylaxis

A

MI, Foreign body aspiration, Pulmonary embolism, Seizure disorder, Hypoglycemia, Shock

26
Q

labs and diagnostic testing: anaphylaxis

A

o Any diagnostics ordered should be used to monitor or eliminate other conditions that the presentation of your patient.
o Anaphylaxis is a clinical diagnosis
o Cardiac monitoring/O2 saturation, ABGs, ECG, CXR
* Used for monitoring patient response, exclude differentials
* Likely in the ED setting
o Skin testing is not predictive of anaphylaxis but may be helpful in identifying causative agent post-anaphylactic episode.

27
Q

management of anaphylaxis

A

o Allergen: remove irritating allergen if possible
o Airway: Assess airway, breathing, circulation, and orientation; if needed, support the airway using the least invasive but effective method (eg, bag-valve-mask)
o CPR: Start chest compressions (100/min) if cardiovascular arrest occurs at any time
o Epinephrine: Inject epinephrine 0.3–0.5 mg intramuscularly in the vastus lateralis (lateral thigh)
* Repeat intramuscular epinephrine every 5–15 min for up to 3 injections if the patient is not responding
o Get Help: Call for assistance
o Position: Place adults and adolescents in recumbent position, pregnant people on left side
o Oxygen: Give 8–10 L/min through facemask or up to 100% oxygen as needed;
monitor by pulse oximetry if available
o EMS: Activate EMS (call 911 or local rescue squad) if no immediate response
to first dose of IM epinephrine or if anaphylaxis is moderate to severe
o Fluids: Establish IV line. Keep open with 0.9NL saline